Cara Therapeutics, Inc. (NASDAQ: CARA) today announced the pricing of its underwritten public offering of 4,500,000 shares of its common ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Equity Offerings

Cara Therapeutics (CARA), Entris BioPharma Inc. Report Dosing of First Patient in Phase 2 Trial of Peptelligence-Engineered Oral KORSUVAJuly 19, 2018 8:06 AM Cara Therapeutics Announces Pricing of $85.5 Million Offering of Common StockJuly 18, 2018 8:53 PM Pre-Open Stock Movers 7/18: (CHRS) (FNKO) (GWW) Higher; (SAH) (WIN) (HCSG) Lower (more...)July 18, 2018 9:34 AM After-Hours Stock Movers 07/17: (UUUU) (CHRS) (CSX) Higher; (SAH) (HCSG) (TXN) Lower (more...)July 17, 2018 5:58 PM Cara Therapeutics (CARA) Announces Proposed 4.5M Share Common OfferingJuly 17, 2018 4:25 PM